OSAIC HOLDINGS, INC. - DIFFUSION PHARMACEUTICALS IN ownership

DIFFUSION PHARMACEUTICALS IN's ticker is and the CUSIP is 253748404. A total of 12 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$1,983
-22.1%
594
-3.3%
0.00%
Q1 2023$2,547
-15.1%
614
+2.3%
0.00%
Q4 2022$3,0000.0%6000.0%0.00%
Q3 2022$3,000
-25.0%
6000.0%0.00%
Q2 2022$4,0006000.00%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 16,565$54,9960.00%
Renaissance Technologies 40,309$1350.00%
VANGUARD GROUP INC 66,232$221,2150.00%
UBS Group AG 60$2000.00%
OSAIC HOLDINGS, INC. 594$1,9830.00%
WELLS FARGO & COMPANY/MN 15$500.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 17,123$56,8480.00%
MORGAN STANLEY 548$1,8300.00%
BlackRock Inc. 32,852$109,7260.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders